How To Exam?

a knowledge trading engine...


Gujarat Technological University 2009 B.Pharm Applied Mathematics (Biostatistics) - Question Paper

Saturday, 20 July 2013 12:50Web



GUJARAT TECHNOLOGICAL UNIVERSITY

B. Pharmacy Sem-II examination June 2009

Subject Name: Applied Mathematics (Biostatistics)

Time : 11:30am-2:30pm Total Marks: 80

Subject code: (220001) Date    : 08/06/09


Instructions: 1.    Attempt any five questions.

2.    Make suitable assumptions wherever necessary.

3.    Figures to the right indicate full marks.

Q-1


A

B


04

05


C


04


What is correlation? Distinguish between positive, negative and zero correlation.

Age

56

42

36

47

49

42

60

72

63

55

(B.P.)

147

125

118

128

145

140

155

160

149

150

i)    Find the correlation coefficient between age and blood pressure.

ii)    Determine least square regression equation of blood pressure on age Estimate the blood pressure of women whose age is 45 years.

A Beers law plot is constructed by plotting ultraviolet absorbance vs. concentration, with following result:_


Concentration ( x)

1

2

3

5

10

Absorbance ( y)

0.10

0.36

0.57

1.09

2.05

XY

0.10

0.72

1.71

5.14

20.50


i)    Calculate slop and intercept

ii)    An unknown has an absorbance of 1.65. What is the concentration?

D Obtain the rank correlation coefficient between Fasting blood glucose level and systolic 03

blood pressure in 10 diabetic patients.

Sr. no of patients

1

2

3

4

5

6

7

8

9

10

Fasting blood

glucose

level(mg/dl)

90

92

98

112

120

121

126

132

143

145

Systolic blood

pressure

(mmHg)

136

140

142

130

148

135

150

170

145

165

Q-2 A What is analysis of variance?    01

C Eight laboratories were requested to participate in experiment whose objective was to 07 compare the dissolution rates of two generic products and standard product. The purpose of the experiment was to determine.

i)    If the product had different rates of dissolution.

ii)    To estimate the laboratory variability and test for significance difference among laboratories. Carry out two-way ANOVA for the given data and give your conclusion

Laboratory

1

2

3

4

5

6

7

8

Generic A Tablet

89

93

87

80

80

87

82

68

Generic B Tablet

83

75

75

76

77

73

80

77

Standard Tablet

94

78

89

85

84

84

75

75

( From the F distribution table- F 2,14= 3.74,F7,24=2.43 and F14 ,24= 2.13 at 5%level of significance )

D The hemoglobin level of three group of children fed on three different diets are given in 05

the following table. Test the means of these three groups differ significantly.

Table: Hemoglobin level (%'

of chi

ldren fed with three different diets.

Sr. no.

1

2

3

4

5

6

7

8

9

10

11

12

Group

I

11.6

10.3

10.0

11.5

11.8

11.8

12.1

10.8

11.9

10.7

11.5

_

Group

II

11.2

8.9

9.2

8.8

8.4

9.1

6.3

9.3

7.8

8.8

10.0

9.7

Group

III

9.8

9.7

11.5

11.6

10.8

9.1

10.5

10.0

12.4

10.7

_

_

( From F distribution table F2,30 = 3.32 at 5%level of significance

Q-3 A Explain the following terms related to testing of hypothesis.    04

i)    Null hypothesis

ii)    Alternate hypothesis

iii)    Level of significance

iv)    Standard error.

B A clinical research center of Zydus Cadila pharmaceutical conducted a pharmacokinetic 06 study in 12 human volunteer. The maximum therapeutic concentration of drug in plasma(C max) was studied after administration of new formulation and established formulation.

06


Established

formulation

(Cmax)mcg/ml

5.6

6.9

5.8

5.8

6.0

5.6

7.1

5.8

5.1

5.7

5.9

4.8

New

formulation (C max) mcg/ml

9.6

5.7

7.8

8.5

9.4

7.9

8.4

13.7

26.9

21.0

17.5

19.6

Test whether there is statistical significance of difference between the two formulations. (t n,0.05=2.20 at 5% significance level)

C The following data shows the blood pressure reduction (in mmHg) caused in 10 animal by a new antihypertensive compound. Test the hypothesis that blood pressure reduction for population in 15 mm Hg. (t9,0.05=2.262 at 5% significance level)

Blood pressure

1 5

18

14

8

90

12

17

21

16

18

reduction (mm Hg.)

08


B


08


Q-5


A

B

C


04 03

05


Q-4 A Enumerate the experimental designs in clinical trials? Discuss in detail about any one experimental design.

Explain following terms with reference to experimental designs in clinical trials. i) Wash out period    ii) Carry over effect

iii) Replicate design    iv) Crossover Design

What is type I and type II errors.

Discuss in brief chi square test or goodness of fit.

Two granulation were prepared by different procedure Seven different random samples of powdered mix of equal weight ( equal to weight Of Final Dosage from) were collected from each batch and assayed for active pharmaceutical ingredient. The test is to be performed at the 5% level. (From F distribution table F 6,0.05=5.8)


Granulation A

20.6

20.9

20.6

20.7

19.8

20.4

21.0

Granulation B

20.2

21.5

18.9

19.0

21.8

20.4

21.0

D A certain drug is claimed to be effective in curing colds. In experiment on 500 person 04 with cold, half of them were given the drug and half of them were given sugar pill. The

patients reaction to the treatment is recorded in following table. On the basis of these data conclude that there is significance difference in the effect of drug and sugar pill. The test is to be performed at the 5% level

(Critical value of Chi square x 2 = 5.99 at 2 d.f.)_

Treatment

Consequence

Helped

Reaction

No effect

Total

Drug

150

30

70

250

Sugar pill

130

40

80

250

Total

230

70

150

500

E Enumerated the various methods of sampling and discuss in detail about any two    08 methods with suitable examples.

What are the advantages of and characteristics of the sample?    03

B

C

D

Q-7 A B

C

D


Differentiate between the sampling with replacement and without replacement    02

A population consists of five numbers 2,3,6,8.11. consider all possible size of two which can be drawn with replacement from this population. Calculate the standard error of sample mean

03

03 06

04


What arte the advantages of nonparametric tests Write note on followings ( any two )

i) Wilcoxon signed rank test ii) Kruskal wallis test iii) Wilcoxon rank sum test.

A Bioavailability study was conducted in which two products were compared ( A and B formulation ) . The peak blood concentrations were as follows; Use Wilcoxon signed rank test to determine if there is a difference among formulation. (Critical value for T at P= 0.05 for 12 pairs from table = 11)

03


Subject

1

2

3

4

5

6

7

8

9

10

11

12

A

2.5

3.0

1.25

1.75

3.5

2.5

1.75

2.25

3.5

2.5

2.0

3.5

B

3.5

4.0

2.5

2.0

3.5

4.0

1.5

2.5

3.0

3.0

3.5

4.0

In the stud

y of cerebrovascu

lar disease, patient

from 3 socioeconomic bac

kgrounds wer

thoroughly investigated. One characteristic measures was diastolic blood pressure (mmHg).Is there any reason to believe that the 3 groups differ with these characteristics?

( Table value of x 2 5.99 at d.

\=k-1=2 and alpha = 0.05)

Group A

100

103

89

78

105

Group B

92

97

88

84

90

95

Group C

81

102

86

83

99

*************



3







Attachment:

( 0 Votes )

Add comment


Security code
Refresh

Earning:   Approval pending.
You are here: PAPER Gujarat Technological University 2009 B.Pharm Applied Mathematics (Biostatistics) - Question Paper